These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38925306)

  • 1. Relationship between Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) total scores in older adults with major depressive disorder: An analysis of the OPTIMUM clinical trial.
    Kim HK; Lenze EJ; Ainsworth NJ; Blumberger DM; Brown PJ; Flint AJ; Karp JF; Lavretsky H; Lenard E; Miller JP; Reynolds CF; Roose SP; Mulsant BH
    J Affect Disord; 2024 Sep; 361():651-658. PubMed ID: 38925306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery-Åsberg Depression Rating Scale and the 9-item Patient Health Questionnaire.
    Kern Sliwa J; Naranjo RR; Turkoz I; Petrillo MP; Cabrera P; Trivedi M
    CNS Spectr; 2024 Jun; 29(3):176-186. PubMed ID: 38557430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant.
    Hudgens S; Floden L; Blackowicz M; Jamieson C; Popova V; Fedgchin M; Drevets WC; Cooper K; Lane R; Singh J
    J Affect Disord; 2021 Feb; 281():767-775. PubMed ID: 33261932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating the HAM-D into the MADRS and vice versa with equipercentile linking.
    Leucht S; Fennema H; Engel RR; Kaspers-Janssen M; Szegedi A
    J Affect Disord; 2018 Jan; 226():326-331. PubMed ID: 29031182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What does the MADRS mean? Equipercentile linking with the CGI using a company database of mirtazapine studies.
    Leucht S; Fennema H; Engel RR; Kaspers-Janssen M; Lepping P; Szegedi A
    J Affect Disord; 2017 Mar; 210():287-293. PubMed ID: 28068617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression.
    Zimmerman M; Posternak MA; Chelminski I
    J Psychiatr Res; 2004; 38(6):577-82. PubMed ID: 15458853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral Antidepressant.
    Floden L; Hudgens S; Jamieson C; Popova V; Drevets WC; Cooper K; Singh J
    CNS Drugs; 2022 Jun; 36(6):649-658. PubMed ID: 35441931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder.
    Fantino B; Moore N
    BMC Psychiatry; 2009 May; 9():26. PubMed ID: 19473506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
    Heo M; Murphy CF; Meyers BS
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Psychometric Properties and Responsiveness to Change of 3 Depression Measures in a Sample of Persons With Traumatic Spinal Cord Injury and Major Depressive Disorder.
    Williams RT; Heinemann AW; Neumann HD; Fann JR; Forchheimer M; Richardson EJ; Bombardier CH;
    Arch Phys Med Rehabil; 2016 Jun; 97(6):929-37. PubMed ID: 26859610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate and severe depression. Gradations for the Montgomery-Asberg Depression Rating Scale.
    Müller MJ; Szegedi A; Wetzel H; Benkert O
    J Affect Disord; 2000 Nov; 60(2):137-40. PubMed ID: 10967373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence to Support Montgomery-Asberg Depression Rating Scale Administration Every 24 Hours to Assess Rapid Onset of Treatment Response.
    Johnson KM; Devine JM; Ho KF; Howard KA; Saretsky TL; Jamieson CA
    J Clin Psychiatry; 2016 Dec; 77(12):1681-1686. PubMed ID: 28086004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidance on the conversion of the Chinese versions of the Quick Inventory of Depressive Symptomatology-Self-Report (C-QIDS-SR) and the Montgomery-Asberg Scale (C-MADRS) in Chinese patients with major depression.
    Liu J; Xiang YT; Lei H; Wang Q; Wang G; Ungvari GS; Morris DW; Zhu XZ; Lai KY; Zhong BL; Wong SY; Zhang L; Zhang Q; Zou YC; Xiao L; Zhao Q; Li Y; Wu J; Zhang GF; Chiu HF
    J Affect Disord; 2014 Jan; 152-154():530-3. PubMed ID: 24144585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing depression severity with a self-rated vs. rater-administered instrument in patients with epilepsy.
    Jamal-Omidi S; Collins C; Fulchiero E; Liu H; Colon-Zimmermann K; Fuentes-Casiano E; Tatsuoka C; Cassidy KA; Lhatoo S; Sajatovic M
    Epilepsy Behav; 2018 Aug; 85():52-57. PubMed ID: 29908384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS).
    Svanborg P; Asberg M
    J Affect Disord; 2001 May; 64(2-3):203-16. PubMed ID: 11313087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between childhood physical abuse and clinical severity of treatment-resistant depression in a geriatric population.
    Yrondi A; Arbus C; Bennabi D; D'Amato T; Bellivier F; Bougerol T; Camus V; Courtet P; Doumy O; Genty JB; Holtzmann J; Horn M; Lancon C; Leboyer M; Llorca PM; Maruani J; Moirand R; Molière F; Petrucci J; Richieri R; Samalin L; Stephan F; Vaiva G; Walter M; ; Haffen E; Aouizerate B; El-Hage W
    PLoS One; 2021; 16(4):e0250148. PubMed ID: 33878137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial.
    Sheline YI; Pieper CF; Barch DM; Welsh-Bohmer K; McKinstry RC; MacFall JR; D'Angelo G; Garcia KS; Gersing K; Wilkins C; Taylor W; Steffens DC; Krishnan RR; Doraiswamy PM
    Arch Gen Psychiatry; 2010 Mar; 67(3):277-85. PubMed ID: 20194828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of depressive symptoms in patients with coronary artery disease using the Montgomery Åsberg Depression Rating Scale.
    Bunevicius A; Staniute M; Brozaitiene J; Pommer AM; Pop VJ; Montgomery SA; Bunevicius R
    Int Clin Psychopharmacol; 2012 Sep; 27(5):249-55. PubMed ID: 22869009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equating the PHQ-9 and GAD-7 to the HADS depression and anxiety subscales in patients with major depressive disorder.
    Huang XJ; Ma HY; Wang XM; Zhong J; Sheng DF; Xu MZ
    J Affect Disord; 2022 Aug; 311():327-335. PubMed ID: 35598748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.